Unknown

Dataset Information

0

CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin.


ABSTRACT: CYLD is a tumour-suppressor gene that is mutated in a benign skin tumour syndrome called cylindromatosis. The CYLD gene product is a deubiquitinating enzyme that was shown to regulate cell proliferation, cell survival and inflammatory responses, mainly through inhibiting NF-kappaB signalling. Here we show that CYLD controls cell growth and division at the G(1)/S-phase as well as cytokinesis by associating with alpha-tubulin and microtubules through its CAP-Gly domains. Translocation of activated CYLD to the perinuclear region of the cell is achieved by an inhibitory interaction of CYLD with histone deacetylase-6 (HDAC6) leading to an increase in the levels of acetylated alpha-tubulin around the nucleus. This facilitates the interaction of CYLD with Bcl-3, leading to a significant delay in the G(1)-to-S-phase transition. Finally, CYLD also interacts with HDAC6 in the midbody where it regulates the rate of cytokinesis in a deubiquitinase-independent manner. Altogether these results identify a mechanism by which CYLD regulates cell proliferation at distinct cell-cycle phases.

SUBMITTER: Wickstrom SA 

PROVIDER: S-EPMC2775896 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4220159 | biostudies-literature
| S-EPMC5104517 | biostudies-literature
| S-EPMC7219287 | biostudies-literature
| S-EPMC7925679 | biostudies-literature
| S-EPMC3337989 | biostudies-literature
| S-EPMC2276399 | biostudies-literature
| S-EPMC2593373 | biostudies-other
| S-EPMC3108987 | biostudies-literature
| S-EPMC2763324 | biostudies-literature
| S-EPMC3663524 | biostudies-literature